All News

Study finds widespread vitamin and mineral use among cancer survivors

FDA approves revised labeling for Thrombin-JMI.

NACDS launches advertising campaign touting pharmacy.

The National Council for Prescription Drug Programs urges physicians to get going on ordering tamper-resistant Rx pads.

FDA approves zotarolimus drug-eluting stent

Create a plan to standardize your process and and training to help prevent mistakes.

Pharmacists should spread the word that they are the medication experts.

Consumers Union petitions FDA to make it easier for patients to report side effects from prescription drugs

FDA, NuCel Labs recalls eye drops and eye/ear wash products

Medicare Part D grows by 1.5 million beneficiaries while remaining under budget.

FDA finds increased risk of suicide in patients taking seizure drugs

Teamsters went on strike for one day at an AmerisourceBergen distribution center.

A pharmacist accused of selling steroids to athlete committed suicide in New York.

Survey finds a low drug compliance rate among schizophrenic patients

Merck extends its Emend line with a new intravenous form

Drug Enforcement Administration proposes placing indiplon in Schedule IV

Study finds that certain OTC eardrops may cause hearing loss or damage

American Legacy Foundation applauds NYS petition to expand access to OTC nicotine medication

NACDS applauds bill that preserves access to retail pharmacies for TRICARE beneficiaries

Rite Aid pharmacists educate customers during National Heart Month

According to a U.S. Pharmacopeia study, at least 1.4% of medication errors results from look-alike and sound-alike drugs.

ONDCP launches initiative to combat teen prescription drug abuse

AIDS Healthcare Foundation has opened an AHF Pharmacy in Fort Lauderdale, Fla.

A Decision Resources report sees a strong future for a Schering-Plough/Novartis asthma drug

Nephrologists can expect some new IV iron and phosphate binder products to be launched this year

The Academy of Managed Care Pharmacy expands on its document on medication therapy management

ImaRx Therapeutics' urokinase gains an additional 20 months of expiration dating

CMS proposes rule to revise DMEPOS supplier standards